TLR9-based immunotherapy for allergic disease.


A significant amount of data generated over the last few years supports the contention that Toll-like receptor (TLR) 9-based immunotherapy is effective in the prevention and treatment of animal models of allergic disorders. We will review here our experience with two distinct therapeutic strategies: TLR9-based immunomodulation and TLR9-based vaccination… (More)


Cite this paper

@article{Hayashi2006TLR9basedIF, title={TLR9-based immunotherapy for allergic disease.}, author={Tomoko Hayashi and Eyal Raz}, journal={The American journal of medicine}, year={2006}, volume={119 10}, pages={897.e1-6} }